
Bruce Jackson
Stock Analyst at StoneX
(0.07)
# 4,778
Out of 5,081 analysts
305
Total ratings
35.5%
Success rate
-10.6%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Reiterated: Buy | $16 → $20 | $16.59 | +20.55% | 25 | Oct 6, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $13 → $15 | $3.89 | +285.60% | 12 | Aug 20, 2026 | |
| PODD Insulet | Reiterated: Buy | $250 → $185 | $149.01 | +24.15% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $77 → $82 | $77.94 | +5.21% | 2 | Jul 31, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 | $18.34 | +9.05% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1 → $2 | $0.4354 | +359.35% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Reiterated: Buy | $3 | $0.7891 | +280.18% | 20 | May 19, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $17.43 | - | 1 | May 11, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $120 | $103.70 | +15.72% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Reiterated: Buy | $14 → $10 | $6.99 | +43.06% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $20 | $2.00 | +900.00% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $6 | $8.23 | -27.10% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $217 | $147.33 | +47.29% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $3.88 | +698.97% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.25 → $1 | $0.305 | +227.87% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.88 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $140 | $0.448 | n/a | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1741 | n/a | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $8.46 | n/a | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.75 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.5475 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.35 → $2 | $1.69 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $24 | $2.20 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.437 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $0.4 | $0.000001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $960 → $240 | $0.000001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $22.61 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $2.83 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.919 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $3.14 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.40 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.97 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.11 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.3028 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $38.06 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.91 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.00 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $11.91 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $95.41 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $45.69 | n/a | 2 | Mar 2, 2012 |
NeoGenomics
Oct 6, 2026
Reiterated: Buy
Price Target: $16 → $20
Current: $16.59
Upside: +20.55%
Unicycive Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $3.89
Upside: +285.60%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $250 → $185
Current: $149.01
Upside: +24.15%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $77 → $82
Current: $77.94
Upside: +5.21%
MiniMed Group
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $18.34
Upside: +9.05%
Humacyte
Jun 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.4354
Upside: +359.35%
Biofrontera
May 19, 2026
Reiterated: Buy
Price Target: $3
Current: $0.7891
Upside: +280.18%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $17.43
Upside: -
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $120
Current: $103.70
Upside: +15.72%
CapsoVision
Mar 27, 2026
Reiterated: Buy
Price Target: $14 → $10
Current: $6.99
Upside: +43.06%
Mar 20, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $2.00
Upside: +900.00%
Mar 16, 2026
Reiterated: Buy
Price Target: $20 → $6
Current: $8.23
Upside: -27.10%
Mar 3, 2026
Reiterated: Buy
Price Target: $187 → $217
Current: $147.33
Upside: +47.29%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $3.88
Upside: +698.97%
Nov 20, 2025
Reiterated: Buy
Price Target: $1.25 → $1
Current: $0.305
Upside: +227.87%
Nov 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $10.88
Upside: -
Sep 15, 2025
Reiterated: Buy
Price Target: $280 → $140
Current: $0.448
Upside: n/a
Sep 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.1741
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $30
Current: $8.46
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $1.75
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.5475
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $1.35 → $2
Current: $1.69
Upside: n/a
Apr 15, 2024
Reiterated: Buy
Price Target: $40 → $24
Current: $2.20
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.437
Upside: n/a
Mar 22, 2024
Reiterated: Buy
Price Target: $4 → $0.4
Current: $0.000001
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: $960 → $240
Current: $0.000001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $22.61
Upside: n/a
Aug 24, 2023
Reiterated: Buy
Price Target: $9 → $5
Current: $2.83
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.919
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $8 → $4
Current: $3.14
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.40
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $8
Current: $4.97
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.11
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.3028
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $38.06
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.91
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.00
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $11.91
Upside: n/a
Nov 21, 2012
Reiterated: Hold
Price Target: $46
Current: $95.41
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $45.69
Upside: n/a